FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15070911000001106: Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
53371001000001116 Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
53371101000001115 Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Is a Azithromycin 200mg/5ml oral suspension 15 ml true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Has AMP Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Azithromycin true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Has specific active ingredient Azithromycin dihydrate false Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Has specific active ingredient Azithromycin true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Azithromycin 200mg/5ml oral suspension (Sigma Pharmaceuticals Plc) 15 ml Has basis of strength substance Azithromycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start